Long-term safety and efficacy of the fully human CAR-T therapy CT103A in relapsed/refractory multiple myeloma.

Mol Ther · 2025 · PMC12172173 · PMID 39520053

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

A clear trend was also observed in the survival time and AUC 0-∞ of CAR-T cells between the two groups.

also in 17,870 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.